Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Imarc Group
www.imarcgroup.com/
Kanika Sharma
sales@imarcgroup.com

Bookmark and Share
Epedigree Software Market Size to Hit USD 16.8 Billion by 2033: Key Trends & Forecast
The global epedigree software market size reached USD 5.6 Billion in 2024.


Epedigree Software Market
BriefingWire.com, 8/06/2025 - The global epedigree software market size reached USD 5.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 16.8 Billion by 2033, exhibiting a growth rate (CAGR) of 12.37% during 2025-2033. 

Grab a sample PDF of this report: https://www.imarcgroup.com/epedigree-software-market/requestsample

The demand for ePedigree software is propelled by stringent regulations like the U.S. Drug Supply Chain Security Act and the EU’s Falsified Medicines Directive, which mandate serialized tracking to ensure pharmaceutical authenticity. The global counterfeit drug market, valued at $200 billion annually, highlights the critical need for secure supply chains. Rising consumer demand for drug safety further accelerates adoption.

Technologies like RFID and barcodes enhance traceability, offering scalable, cost-effective solutions. Integration with ERP and SCM systems streamlines operations, with North America holding 36% market share due to robust regulations. Cloud-based solutions and digital transformation in pharmaceuticals, led by companies like TraceLink and SAP SE, drive market expansion by ensuring compliance and transparency.

Key Market Trends & Insights:

Blockchain Integration

Blockchain provides tamper-proof records, enhancing transparency in ePedigree systems. TraceLink’s blockchain-based solutions ensure secure drug tracking, with over 9 million U.S. pharmaceutical shipments tracked annually, demonstrating its impact on reducing counterfeit risks and ensuring supply chain integrity.

Cloud-Based Solutions

Cloud-based ePedigree software offers scalability and cost-effectiveness. Oracle’s cloud platforms enable real-time data access across global supply chains, reducing infrastructure costs for SMEs. Approximately 70% of new ePedigree adoptions favor cloud deployments for their flexibility and regulatory compliance efficiency.

AI and Analytics

AI-driven analytics optimize ePedigree systems by predicting supply chain issues. SAP SE’s AI platforms enhance compliance through anomaly detection. Over 60% of pharmaceutical companies report improved efficiency, leveraging AI for real-time insights into product movement and safety.

IoT Integration

IoT technologies like RFID tags enable real-time tracking in ePedigree systems. Axway’s IoT solutions ensure drug authenticity from manufacturer to consumer. About 80% of large pharmaceutical firms use IoT for unit-level tracking, enhancing supply chain security and counterfeiting prevention.

Serialization and Traceability

Serialization assigns unique identifiers to products, ensuring traceability. TraceLink’s software supports compliance with regulations like the DSCSA by tracking serial numbers. Around 90% of U.S. pharmaceutical products are serialized, bolstering efforts to combat counterfeiting and ensure product integrity.

Ask analyst of customized report: https://www.imarcgroup.com/request?type=report&id=6690&flag=E

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2026 Proserve Technology, Inc.